Pure Global AI
NCT06347614Recruitment Completed

Modified Radical Prostatectomy for Prostate Cancer Patients With Enlarged Prostate and Severe Lower Urinary Tract Symptoms: a Single-center, Retrospective Study

Sun Yat-sen UniversityClinicalTrials.govprocedure
Verified
Study focus
Disease/Condition
Prostate Cancer
Drug/Device/Intervention
Two-step Radical Prostatectomy
Study type
Observational
Intervention type
procedure
Sponsor & location
Primary sponsor
Sun Yat-sen University
Location
Guangzhou, China
Timeline & enrollment
Phase
N/A
Start date
Sep 01, 2021
End date
Dec 31, 2024
Enrollment
30 participants
Primary outcome

Biochemical Recurrence-free Survival

Summary

The goal of this retrospective, observational study is to preliminarily learn about the
 safety and efficacy of two-step radical prostatectomy in the treatment of low- to
 intermediate-risk prostate cancer patients with enlarged prostate and severe benign prostatic
 hyperplasia. The main questions it aims to answer are: 1. Whether two-step prostatectomy is
 safe enough to decrease the surgical difficulty of these patients? 2. Whether the oncologic
 control is promising?

ICD-10 classifications
Malignant neoplasm of prostateHyperplasia of prostateDisorder of prostate, unspecifiedOther disorders of prostateCarcinoma in situ: Prostate
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06347614
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06347614 through Pure Global AI's free database. This phase not specified trial is sponsored by Sun Yat-sen University and is currently Recruitment Completed. The study focuses on Prostate Cancer. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.